These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 4740236)

  • 41. [Evaluation of the action of p-chlorophenoxy alpha-isobutyrate of 3-hydroxymethyl pyridine hydrochloride on peripheral circulation. Rheographic and radioisotope studies].
    Modica G; Ferrante R
    Minerva Cardioangiol; 1973 Dec; 21(12):769-74. PubMed ID: 4592148
    [No Abstract]   [Full Text] [Related]  

  • 42. [Treatment of peripheral circulation disorders of lower extremities with Flunarizine and papaverine].
    Brugmans J; Jageneau A; Adriaensen H
    Med Welt; 1977 Jun; 28(23):1056-64. PubMed ID: 886962
    [No Abstract]   [Full Text] [Related]  

  • 43. Vasodilators for arterial insufficiency.
    Naide D
    Am Fam Physician; 1980 Jul; 22(1):128-9. PubMed ID: 7386349
    [No Abstract]   [Full Text] [Related]  

  • 44. [Clinical experimentation with a new vasodilator: cinepazide maleate in arterial diseases of the lower limbs].
    Warembourg G; Carre A; Ginestet A; Lambert M
    Lille Med; 1976 Dec; 21 Suppl 4():898-901. PubMed ID: 1018614
    [No Abstract]   [Full Text] [Related]  

  • 45. [Doppler flowmeter evaluation of the effects of the administration of buflomedil (irrodan) on peripheral circulation in patients with obstructive chronic arteriopathy].
    Abate S; Ferulano GP; Vanni L; Dilillo S; Picilli M; D'Alessio E
    Minerva Cardioangiol; 1985 Nov; 33(11):749-56. PubMed ID: 2935748
    [No Abstract]   [Full Text] [Related]  

  • 46. [Peridural anesthesia. 3. Its usefulness in therapy of acute and chronic arteriopathies].
    Raso AM; Silvestrini P
    Chirurgia (1951); 1972 Aug; 21(8):743-6. PubMed ID: 4664488
    [No Abstract]   [Full Text] [Related]  

  • 47. [The therapeutic effects of flunarizine in peripheral arterial diseases and cerebrovascular diseases].
    De Gregorio G; Restivo S
    Clin Ter; 1982 Dec; 103(5):501-7. PubMed ID: 7160142
    [No Abstract]   [Full Text] [Related]  

  • 48. [Raubasine-peridural infiltration combination in therapy of obstructive arteriopathies of the lower extremities].
    Giubbolini G; Setacci C; Romei R; Federici L
    Minerva Cardioangiol; 1980 Mar; 28(3):177-82. PubMed ID: 7383367
    [No Abstract]   [Full Text] [Related]  

  • 49. [Comparative effectiveness of drug preparations given by intraarterial regional infusion to patients with occlusion of the distal arterial bed].
    Silaev IuS; Avchenko MT; Gus'kov OI
    Klin Med (Mosk); 1984 Jun; 62(6):89-93. PubMed ID: 6471805
    [No Abstract]   [Full Text] [Related]  

  • 50. [Effect of fibrinolysis activation on the peripheral blood circulation in occlusive vascular diseases].
    Bielawiec M; Lukjan H
    Med Monatsschr; 1971 Jul; 25(7):312-4. PubMed ID: 5563915
    [No Abstract]   [Full Text] [Related]  

  • 51. [PROLONGED INTRA-ARTERIAL INFUSIONS WITH VASODILATORS AND LOW-MOLECULAR WEIGHT DEXTRAN IN THE TREATMENT OF PERIPHERAL ARTERIAL CIRCULATION DISORDERS].
    MARTI WK
    Schweiz Med Wochenschr; 1963 Dec; 93():1746-9. PubMed ID: 14098621
    [No Abstract]   [Full Text] [Related]  

  • 52. [Experience with Complamin in peripheral circulation disorders].
    Wittenburg H
    Med Monatsschr; 1969 Dec; 23(12):558-61. PubMed ID: 5387170
    [No Abstract]   [Full Text] [Related]  

  • 53. [Experiences with bencyclane in peripheral disorders of arterial blood supply].
    Alánt O; Horváth N
    Arzneimittelforschung; 1970 Oct; 20(10):Suppl 10a:1403+. PubMed ID: 5536654
    [No Abstract]   [Full Text] [Related]  

  • 54. [Effect of vasodilators in peripheral arterial insufficiency].
    Hansteen V; Lorentsen E
    Tidsskr Nor Laegeforen; 1971 Aug; 91(24):1731-4. PubMed ID: 5111131
    [No Abstract]   [Full Text] [Related]  

  • 55. [Rheologic therapy of peripheral arteriopathies. Personal observations on the use of flunarizin].
    Palleschi M; Marci M; Ceraso C; Passacantilli A; Marin P
    Clin Ter; 1984 Aug; 110(3):215-20. PubMed ID: 6237860
    [No Abstract]   [Full Text] [Related]  

  • 56. [Vasodilator activity of cetiedil in patients with peripheral arterial insufficiency and vasospastic changes: hemodynamic study].
    Matesanz JM; Reina T; García F; Acin F; Méndez B; Tamames S
    Med Clin (Barc); 1982 Sep 1-15; 79(4):173-6. PubMed ID: 7144291
    [No Abstract]   [Full Text] [Related]  

  • 57. [Test of active vasodilatation in the evaluation of peripheral regional circulation in sclerotic and diabetic arteriopathies].
    Dughera L; Macchioni P; Di Leo M; Nosenzo C
    Minerva Cardioangiol; 1972 Sep; 20(9):484-96. PubMed ID: 5071470
    [No Abstract]   [Full Text] [Related]  

  • 58. Peripheral arterial disease: drug therapy.
    Schwartz JB
    J Gend Specif Med; 2002; 5(4):16-20. PubMed ID: 12192882
    [No Abstract]   [Full Text] [Related]  

  • 59. [Therapeutic value of a new anti-ischemic and vaso-regulating drug: Cètièdil].
    Linquette M; Fossati P; Luez G
    Lille Med; 1973 Dec; 18(10 Suppl 5):suppl 5:1303-12. PubMed ID: 4802992
    [No Abstract]   [Full Text] [Related]  

  • 60. [Analysis of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine. 1. Spectroscopy of 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine].
    Hinze HJ
    Arzneimittelforschung; 1971 Oct; 21(10):1456-9. PubMed ID: 5171860
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.